Immunai vs Starget Pharma
Immunai vs Starget Pharma, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunai is on 69/100 and Starget Pharma on 50/100.
Where each one leads
Immunai
- our overall score: 69/100 against 50/100
- agent readiness: 32/100 against 25/100
- domain rating: 46/100 against 17/100
- headcount: 179 against 21
- funding raised: $295M against $15.1M
- LinkedIn following: 26,832 against 1,299
Starget Pharma
- headcount growth: +54.1% against +13.0%
At a glance
| Measure | Immunai | Starget Pharma |
|---|---|---|
| What it is | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. | Early-stage clinical company developing smart targeted radioligands for precision oncology. |
| Category | Healthcare, Immunology, Data, Analytics | Healthcare, Oncology, Life Sciences, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2019 | 2019 |
| Headquarters | New York, United States | Not published |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Immunai | Starget Pharma |
|---|---|---|
| Employees | 179 | 21 |
| Headcount growthLast 12 months | +13.0% | +54.1% |
| Total funding | $295M | $15.1M |
| Latest round | Series B | Series B |
| Valuation | $1.0B | $19.5M |
| LinkedIn followers | 26,832 | 1,299 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunai | Starget Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 50/100 |
| Traction | 60/100 | 49/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 39/100 | 28/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (25/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 17/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunai | Starget Pharma |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Not detected | CloudFront |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Bootstrap | Next.js |
| Analytics | Google Tag Manager | Not detected |
Immunai vs Starget Pharma: common questions
Which is better, Immunai or Starget Pharma?
On our 0-100 score Immunai rates higher (69/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Immunai and Starget Pharma compare on the numbers?
Immunai leads on our overall score (69/100 against 50/100), agent readiness (32/100 against 25/100), domain rating (46/100 against 17/100), headcount (179 against 21), funding raised ($295M against $15.1M), LinkedIn following (26,832 against 1,299). Starget Pharma leads on headcount growth (+54.1% against +13.0%).
Read the full Immunai review and pricing or the Starget Pharma review and pricing. You can also browse other Immunai alternatives we track.